56 related articles for article (PubMed ID: 9504857)
1. Specific and sensitive detection of the EWS/FLI1 fusion protein in Ewing's sarcoma by Western blotting.
Wang M; Nilsson G; Carlberg M; Dricu A; Wejde J; Kreicbergs A; Larsson O
Virchows Arch; 1998 Feb; 432(2):131-4. PubMed ID: 9504857
[TBL] [Abstract][Full Text] [Related]
2. Promiscuous partnerships in Ewing's sarcoma.
Sankar S; Lessnick SL
Cancer Genet; 2011 Jul; 204(7):351-65. PubMed ID: 21872822
[TBL] [Abstract][Full Text] [Related]
3. Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.
de Alava E; Panizo A; Antonescu CR; Huvos AG; Pardo-Mindán FJ; Barr FG; Ladanyi M
Am J Pathol; 2000 Mar; 156(3):849-55. PubMed ID: 10702401
[TBL] [Abstract][Full Text] [Related]
4. BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.
Wiles ET; Lui-Sargent B; Bell R; Lessnick SL
PLoS One; 2013; 8(3):e59369. PubMed ID: 23527175
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF, available for diagnosis.
Urano F; Umezawa A; Yabe H; Hong W; Yoshida K; Fujinaga K; Hata J
Jpn J Cancer Res; 1998 Jul; 89(7):703-11. PubMed ID: 9738976
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the molecular pathogenesis of Ewing's sarcoma.
Toomey EC; Schiffman JD; Lessnick SL
Oncogene; 2010 Aug; 29(32):4504-16. PubMed ID: 20543858
[TBL] [Abstract][Full Text] [Related]
7. Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.
Xiao Y; Zhi Y; Cao G; Ma H; Gao J; Li F
J Cancer Res Clin Oncol; 2024 May; 150(5):267. PubMed ID: 38769118
[TBL] [Abstract][Full Text] [Related]
8. Ewing's sarcoma: overcoming the therapeutic plateau.
Subbiah V; Kurzrock R
Discov Med; 2012 Jun; 13(73):405-15. PubMed ID: 22742646
[TBL] [Abstract][Full Text] [Related]
9. Targeted Therapy of Ewing's Sarcoma.
Subbiah V; Anderson P
Sarcoma; 2011; 2011():686985. PubMed ID: 21052545
[TBL] [Abstract][Full Text] [Related]
10. [Ewing's sarcoma of central nervous system: a clinicopathological analysis of six cases].
Yang QY; Li H; Liu C; Bao ML; Fan QH; Pan MH
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1249-1254. PubMed ID: 38058042
[No Abstract] [Full Text] [Related]
11. Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma.
Herrero-Martin D; Fourtouna A; Niedan S; Riedmann LT; Schwentner R; Aryee DN
Sarcoma; 2011; 2011():352580. PubMed ID: 22135504
[TBL] [Abstract][Full Text] [Related]
12. Is There a Predisposition Gene for Ewing's Sarcoma?
Randall RL; Lessnick SL; Jones KB; Gouw LG; Cummings JE; Cannon-Albright L; Schiffman JD
J Oncol; 2010; 2010():397632. PubMed ID: 20300555
[TBL] [Abstract][Full Text] [Related]
13. Cross contamination meets misclassification: Awakening of CHP-100 from sleeping beauty sleep-A reviewed model for Ewing's sarcoma.
Dirks WG; Capes-Davis A; Eberth S; Fähnrich S; Wilting J; Nagel S; Steenpass L; Becker J
Int J Cancer; 2021 May; 148(10):2608-2613. PubMed ID: 33460449
[TBL] [Abstract][Full Text] [Related]
14.
Joseph J; Prabhu K; Jonathan E; Jesudason MR; Gupta AK
J Craniovertebr Junction Spine; 2024; 15(1):110-113. PubMed ID: 38644918
[TBL] [Abstract][Full Text] [Related]
15. Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease.
Simmons O; Maples PB; Senzer N; Nemunaitis J
ISRN Oncol; 2012; 2012():247657. PubMed ID: 22523703
[TBL] [Abstract][Full Text] [Related]
16. Specificity and function of monoclonal antibodies directed against Ewing sarcoma cells.
Shi LR; Eichelbauer D; Borchard F; Jürgens H; Göbel U; Schneider EM
Cancer Immunol Immunother; 1994 Mar; 38(3):208-13. PubMed ID: 8124690
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of ETAA16: a novel cell surface antigen in Ewing's tumours.
Borowski A; Dirksen U; Lixin L; Shi RL; Göbel U; Schneider EM
Cancer Immunol Immunother; 2006 Apr; 55(4):363-74. PubMed ID: 16003559
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapy for sarcomas.
Forscher C; Mita M; Figlin R
Biologics; 2014; 8():91-105. PubMed ID: 24669185
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Signalling of Growth Factor Receptors in Cancer: Mechanisms and Therapeutic Opportunities.
Dricu A
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806381
[TBL] [Abstract][Full Text] [Related]
20. Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review).
Cerrone M; Cantile M; Collina F; Marra L; Liguori G; Franco R; De Chiara A; Botti G
Int J Mol Med; 2014 Jun; 33(6):1379-91. PubMed ID: 24714847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
